Amanote Research

Amanote Research

    RegisterSign In

Cell Therapies for Duchenne Muscular Dystrophy: Some Ethical Issues for Personalised Medicines

Orphanet Journal of Rare Diseases - United Kingdom
doi 10.1186/1750-1172-5-s1-p8
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineGeneticsPharmacology
Date

October 1, 2010

Authors
Pauline McCormack
Publisher

Springer Science and Business Media LLC


Related search

Therapy of Genetic Disorders: Novel Therapies for Duchenne Muscular Dystrophy

Current Pediatrics Reports
2014English

Emerging Drugs for Duchenne Muscular Dystrophy

Expert Opinion on Emerging Drugs
Pharmacology
2012English

Gene Therapy for Duchenne Muscular Dystrophy

Archives of Neurology
2007English

Duchenne Muscular Dystrophy

Physiotherapy
Physical TherapySports TherapyRehabilitation
1990English

Duchenne Muscular Dystrophy

English

Duchenne Muscular Dystrophy

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

Duchenne Muscular Dystrophy

2020English

Genome Editing Gene Therapy for Duchenne Muscular Dystrophy

Journal of Neuromuscular Diseases
Neurology
2015English

Mesenchymal Stem Cells: Emerging Therapy for Duchenne Muscular Dystrophy

PM and R
Physical TherapySports ScienceSports TherapyNeurologyMedicineRehabilitation
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy